We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Tougher sentences for cowardly killers delivered a year on from Wade Review.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Documents relating to Ofqual's requirements to meet the Business Impact Target
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Information about IOM, which allows local and partner agencies to co-ordinate the management of offenders, including details of the Choices programme.
This page includes summaries of the winning bids for the Digital Connectivity Infrastructure Accelerator (DCIA) pilots competition
Engage with our reform programme, get involved and stay updated on progress.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Progress update explaining the process for rationalising output and outcome monitoring indicators for future funding.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.